Lyfeed Pharmaceuticals Private Limited
About Lyfeed Pharmaceuticals Private Limited
Data last updated:
Lyfeed Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 13 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2020PTC360186. Its GSTIN is 07AAECL1344D1ZY (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Snigdha Rani Bhuyan and Narayan Chandra Rout.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No 153 Right Portion First Floor Village Mangolpur Kalan Rohini, New Delhi, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹38,492, a decline of 23% compared to the previous year. For the same year it recorded a net loss of ₹11,056 (net margin -28.7%) and EBITDA of -₹10,518 (EBITDA margin -27.3%). Revenue has declined at a compounded annual rate (CAGR) of 38% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH.No 153 Right Portion First Floor Village Mangolpur Kalan Rohini, New Delhi, Delhi, India – 110085
- IndustryHealthcare, Human Health Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Lyfeed Pharmaceuticals Private Limited
The main business activity of Lyfeed Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Lyfeed Pharmaceuticals Private Limited FY 2025 filings available
Lyfeed Pharmaceuticals Private Limited reported revenue of ₹38,492 (down 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Lyfeed Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 38% over three years, including a 23% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Lyfeed Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹10,518 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹11,056 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Lyfeed Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -27.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -28.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Lyfeed Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Lyfeed Pharmaceuticals Private Limited
Lyfeed Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Clump Pharmaceuticals Private Limited | ₹40,000 (FY 2021) | •••• | •••• | •••• | Delhi, India | |
| Unigrace Pharmaceuticals Private Limited | ₹39,966 (FY 2023) | •••• | •••• | -51.0% | •••• | Mumbai, Maharashtra, India |
| Dasm Pharmaceuticals Private Limited | ₹38,920 (FY 2020) | •••• | •••• | •••• | Kalyan, Maharashtra, India | |
| Bluzin Pharmaceuticals Private Limited | ₹38,763 (FY 2022) | •••• | •••• | -64.0% | •••• | Mathura, Uttar Pradesh, India |
| Aween Pharmaceuticals Private Limited | ₹38,500 (FY 2019) | •••• | •••• | •••• | Narayanpur, Bihar, India | |
| Lyfeed Pharmaceuticals Private Limited this company | ₹38,492 (FY 2025) | •••• | •••• | -23.0% | •••• | New Delhi, Delhi, India |
| Pirincs Pharmaceuticals Private Limited | ₹37,830 (FY 2023) | •••• | •••• | 5905.0% | •••• | Lucknow, Uttar Pradesh, India |
| C I Pharmaceuticals Pvt. Ltd | ₹37,816 (FY 2025) | •••• | •••• | 3.0% | •••• | Kolkata, West Bengal, India |
| Mizzle Drugs and Pharmaceuticals Private Limited | ₹37,736 (FY 2018) | •••• | •••• | -57.0% | •••• | Madurai, Tamil Nadu, India |
| Tutelage Pharmaceuticals Private Limited | ₹37,500 (FY 2021) | •••• | •••• | •••• | Bareilly, Uttar Pradesh, India | |
| Indoerwin Pharmaceuticals Private Limited | ₹37,047 (FY 2021) | •••• | •••• | •••• | Bengaluru, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Lyfeed Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Lyfeed Pharmaceuticals Private Limited
Lyfeed Pharmaceuticals Private Limited is audited by SUNIL CHAURASIA & CO. for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SUNIL CHAURASIA & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Lyfeed Pharmaceuticals Private Limited
Lyfeed Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Snigdha Rani Bhuyan | Director | 13 Jan 2020 | 6 Years 9 Months | Current |
| Narayan Chandra Rout | Director | 27 Dec 2021 | 4 Years 9 Months | Current |
Ownership and Shareholding of Lyfeed Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Lyfeed Pharmaceuticals Private Limited
Lyfeed Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Lyfeed Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Lyfeed Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Lyfeed Pharmaceuticals Private Limited
Lyfeed Pharmaceuticals Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Narayan Chandra Rout ceased to be Additional Director on 30 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Lyfeed Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Lyfeed Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Lyfeed Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Lyfeed Pharmaceuticals Private Limited
Lyfeed Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECL1344D1ZY | Delhi | Active | 29 Jan 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Lyfeed Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lyfeed Pharmaceuticals Private Limited
Lyfeed Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in human health activities, within the healthcare industry. It was incorporated on 13 January 2020 (6+ years old) and is registered under CIN U85100DL2020PTC360186.
Lyfeed Pharmaceuticals reported revenue of ₹38,492 for FY 2025 (down 23% YoY).
Lyfeed Pharmaceuticals has 2 current directors:
- Snigdha Rani Bhuyan - Director
- Narayan Chandra Rout - Director
Lyfeed Pharmaceuticals reported a net loss of ₹11,056 (net margin -28.7%) and EBITDA of -₹10,518 (EBITDA margin -27.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Lyfeed Pharmaceuticals is -38% over three years. In the latest year (FY 2025) revenue fell 23%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Lyfeed Pharmaceuticals is 07AAECL1344D1ZY, registered in Delhi.
The CIN (Corporate Identification Number) of Lyfeed Pharmaceuticals is U85100DL2020PTC360186. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lyfeed Pharmaceuticals was incorporated on 13 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Lyfeed Pharmaceuticals by revenue are Clump Pharmaceuticals Private Limited, Unigrace Pharmaceuticals Private Limited, Dasm Pharmaceuticals Private Limited, Bluzin Pharmaceuticals Private Limited, Aween Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Narayan Chandra Rout ceased to be Additional Director on 30 Sep 2022. Narayan Chandra Rout was appointed as Director on 27 Dec 2021. Satyajit Rout ceased to be Director on 27 Dec 2021. Lyfeed Pharmaceuticals has 4 board changes on record in total.
The registered office of Lyfeed Pharmaceuticals is at H.No 153 Right Portion First Floor Village Mangolpur Kalan Rohini, New Delhi, Delhi, India – 110085.